Navigation Links
BioTech Holdings Identifies and Files Patent on ProCell Mechanism of Action in Saving Limbs from Amputation
Date:10/9/2017

SAN DIEGO, Oct. 9, 2017 /PRNewswire/ -- BioTech Holdings announced today identification and patenting of a biological mechanism by which its ProCell stem cell therapy prevents limb loss in animal models of critical limb ischemia.  The Company, demonstrated that treatment with ProCell resulted in more than double the amount of limbs saved as compared to standard bone marrow stem cell administration.  Interestingly, neutralization of the molecule HGF resulted in reduction of therapeutic effect. 

Critical limb ischemia is a condition, primarily in diabetics, that causes 250,000 amputations per year in the USA.  At present there is no medical treatment for this condition and surgical approaches are applicable to less than half of patients.

ProCell is a personalized stem cell therapy using the an FDA approved peptide hormone to stimulate new blood vessel production in patients whose tissues lack oxygen, a condition termed "ischemia." In addition to critical limb ischemia, lack of oxygen is associated with heart failure and stroke.

"The identification of HGF-1 as a mechanism by which ProCell mediates its therapeutic effects is a major step forward in our developmental path towards FDA IND filing," said Thomas Ichim, Ph.D, President and CEO of BioTech Holdings. "We are aggressively filing intellectual property on this useful biomarker, which will assist us in optimizing doses as we enter formal clinical trials in the USA."

BioTech Holdings previously reported efficacy signals in a pilot study of critical limb ischemia patients.  The Company plans to file its Investigational New Drug application with the FDA before year end.

Contacts

Thomas E Ichim, Ph.D
President and Chief Executive Officer
BioTech Holdings
9255 Towne Centre Drive, #450
San Diego, CA 92121
179878@email4pr.com
858 353 4303
Twitter: @biotechholdings

 

View original content with multimedia:http://www.prnewswire.com/news-releases/biotech-holdings-identifies-and-files-patent-on-procell-mechanism-of-action-in-saving-limbs-from-amputation-300533444.html


'/>"/>
SOURCE BioTech Holdings
Copyright©2017 PR Newswire.
All rights reserved


Related biology technology :

1. Arzeda and TeselaGen Partner to Advance Biodesign Technologies for Industrial Biotechnology
2. FierceBiotech Reveals the Fierce 15 Winners of 2017
3. DrugDev to Promote Adoption of Innovative Technologies to Advance Clinical Study Efficiency at Prestigious Pharma and Biotech Industry Conferences in Q4
4. Pharma, Biotech Clinical Trial Leaders to Convene for 3rd Annual DrugDev Summit to Promote Collaboration, Technology Innovation, Engaged Sites, and More Informed Patients
5. PRC Clinical Partners With SDC to Expand ClinPulse Event Series to the Boston Biotech Hub
6. Demand for DrugDev Spark™ Soars Among Small Biotechs and Pharma Seeking Best-in-Class Technology for Clinical Trial Planning, Startup and Conduct
7. Biotech Pioneer BIOLIFE4D Submits Regulation A+ Filing with SEC for up to $50 Million Initial Public Offering
8. Lifecycle Biotechnologies Announces Promotion of Ashley Wilhelm to Customer Outcomes Manager
9. The Art of Science Inspires Residency Program at Biotech Company
10. Lesaffre Invests in Intralytix, a US Biotechnology Company
11. Panitch Schwarze Life Sciences Practice Leader Speaks at Biotechnology Conference in Shanghai
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/4/2019)... ... January 02, 2019 , ... CellMax Life , a ... blood, has been named as a partner in Medigen Biotech’s upcoming cell therapy ... for cancer treatment, will use CellMax Life’s circulating tumor cell platform CMxTM, in ...
(Date:12/18/2018)... ... December 17, 2018 , ... ABCT ... emerging biosciences ventures invited to participate in the annual program. Twelve ventures will ... plans and a professional network. All startups receive an entrepreneur coach, access to ...
(Date:12/13/2018)... (PRWEB) , ... December 12, 2018 , ... ... other life science software solutions, announces the Limfinity® ML (Machine Learning) addition for ... trained machine learning models within Limfinity® solutions. In the module, trained models make ...
(Date:12/5/2018)... Netherlands (PRWEB) , ... December 05, 2018 , ... The ... week paid tribute to in the European Parliament by Carlos Moedas, the European Commissioner ... Conference EU Research and Innovation in Our Daily Lives, Commissioner Moedas spoke at length ...
Breaking Biology Technology:
(Date:1/7/2019)... ... January 07, 2019 , ... Franz ... Graph Database technology for Knowledge Graphs solutions, announced that it was recognized by ... . DBTA’s data and information management recognition list includes newer approaches leveraging ...
(Date:12/27/2018)... ... December 27, 2018 , ... ... discs for implantation at its new Boston facility, and is now raising growth ... inventory to immediately expand market share against inferior ball and socket discs. The ...
(Date:12/19/2018)... ... December 19, 2018 , ... NDA Partners Chairman Carl ... Compliance Officer at the FDA Center for Devices and Radiological Health (CDRH), has been ... an Expert Consultant since 2015, and she has more than 25 years of regulatory ...
Breaking Biology News(10 mins):